granted
on 16 May 2024
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
90824942 filed on 13th Jul 2021
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders; pharmaceutical preparations for the treatment, prev Read More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders; pharmaceutical preparations for the treatment, prevention and diagnosis of neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases
N/A
N/A
No 90824942
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Nov 2024 | TEAS STATEMENT OF USE RECEIVED |
17th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
16th May 2024 | SOU EXTENSION 4 FILED |
16th May 2024 | SOU EXTENSION 4 GRANTED |
16th May 2024 | SOU TEAS EXTENSION RECEIVED |
15th Nov 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
13th Nov 2023 | SOU EXTENSION 3 GRANTED |
13th Nov 2023 | SOU EXTENSION 3 FILED |
13th Nov 2023 | SOU TEAS EXTENSION RECEIVED |
17th May 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |